CD38 (Daratumumab Biosimilar) antibody (Biotin)

Catalog No. ABIN7766323

The Human Monoclonal anti-CD38 (Daratumumab Biosimilar) antibody has been validated for FACS, ELISA and CyTox. It is suitable to detect CD38 (Daratumumab Biosimilar) in samples from Human.

Quick Overview for CD38 (Daratumumab Biosimilar) antibody (Biotin) (ABIN7766323)

Target: CD38 (Daratumumab Biosimilar)

Reactivity: Human

Host: Human

Clonality: Monoclonal

Conjugate: This CD38 (Daratumumab Biosimilar) antibody is conjugated to Biotin

Application: Flow Cytometry (FACS), ELISA, Cytotoxicity Test (CyTox)

Product Details anti-CD38 (Daratumumab Biosimilar) Antibody (Biotin)

Purpose: Conjugated Anti-CD38 (daratumumab biosimilar) mAb

Purification: Purified from cell culture supernatant by affinity chromatography

Application Details

Application Notes: working with enzyme-conjugated streptavidin, most applications: 1: 50 - 1: 1,000

Restrictions: For Research Use only

Handling

Buffer: Liquid in PBS, 0.5 % BSA, 40 % Glycerol, 0.02 % Sodium Azide.

Preservative: Sodium azide

Precaution of Use: This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Handling Advice: Protect from light!

Storage: 4 °C

Storage Comment: Store at 4°C in dark for 6 months

Target Details for CD38 (Daratumumab Biosimilar)

Target: CD38 (Daratumumab Biosimilar)

Alternative Name: daratumumab biosimilar

Target Type: Biosimilar

Background: CD38, T10, ADPRC1